PETER LEE

Allopathic & Osteopathic Physicians|Dermatology METUCHEN, NJ NPI 1124101654

General Payments — all program years on this page

$5,484.44

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 242
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $593.65 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $415.7120
Education $177.942

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $721.3647
2019 $1,115.5152
2020 $460.6325
2021 $748.2936
2022 $972.5039
2023 $872.5021
2024 $593.6522

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078359823 Janssen Biotech, Inc. $12.42 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078359849 Janssen Biotech, Inc. $13.11 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078359872 Janssen Biotech, Inc. $15.68 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078359885 Janssen Biotech, Inc. $94.99 04/24/2024 Education Undisputed 01/23/2026 View at CMS
1087151070 Novartis Pharmaceuticals Corporation $19.52 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101419601 E.R. Squibb & Sons, L.L.C. $15.81 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104155410 ABBVIE INC. $13.18 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117608380 Amgen Inc. $16.08 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117608382 Amgen Inc. $16.09 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117608384 Amgen Inc. $15.00 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135278619 Lilly USA, LLC $16.56 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135284724 Lilly USA, LLC $18.12 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135294155 Lilly USA, LLC $18.98 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135317580 Lilly USA, LLC $18.60 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135317895 Lilly USA, LLC $20.47 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135323989 Lilly USA, LLC $16.28 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139568159 GENZYME CORPORATION $101.92 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145312170 Galderma Laboratories, L.P. $15.36 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152190966 SUN PHARMACEUTICAL INDUSTRIES INC. $82.95 08/28/2024 Education Undisputed 01/23/2026 View at CMS
1152190968 SUN PHARMACEUTICAL INDUSTRIES INC. $18.21 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152190970 SUN PHARMACEUTICAL INDUSTRIES INC. $15.66 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152190972 SUN PHARMACEUTICAL INDUSTRIES INC. $18.66 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.